Indo-MIM Limited

The world cannot make enough engine castings and machined parts: 87% of aerospace programmes report shortages, and castings, forgings and special-process capacity are named as the bottleneck. That market is roughly USD 3.1–4.1 bn growing 7–9% a year, and Indo-MIM has 1.4–1.8% of it, so the space ahead is 55 to 70 times what this segment sells today. Revenue grew 33% in each of the last two years, well ahead of the market, so it is taking share. It does not reach 5 because the growth reconciles to no increase in units made anywhere in the filing, and because the plant bought for exactly this purpose has sat at about 9% of capacity for three years.

The edge is scarce approved capacity. Aerospace buyers cannot move work to an unapproved supplier, and Indo-MIM holds AS9100 and NADCAP approvals, a Pratt & Whitney materials-control approval reported as the first of its kind in India, Rolls-Royce approval at its US plant, and single-crystal casting no Indian rival has. A competitor needs four to six years to match that chain. What holds it at 4 rather than 5: bigger holders of the same approvals exist abroad, the filing names not one programme, engine family or part number, and the company's own aerospace acquisition has been written down by about Rs 180 cr while running near-idle for three years — which is evidence it cannot yet sell what it has.

The market itself is the slower half of the story: parts of this kind for consumer electronics grow about 8% a year, down from 14%, and it is the second-slowest of the company's six end-markets. What carries this business is the space ahead and the fact that it is visibly taking it: export revenue grew 26% and then 29% against a market growing 14% then 8%, with no acquisition behind it and customers rising from 163 to 220. It holds between 4% and 11% of a market that will be 15 to 20 times this segment's revenue, and it can reach that without a rupee of this offer's money, because its moulding plants run at 31% of capacity.

The edge is cost, and it is real: Indian wages at roughly a fifth of Chinese levels, the world's three largest continuous sintering furnaces, feedstock made in-house, and a tool room turning out 45 to 50 tools a month — which is what wins a long tail of small orders. Western rivals earn a third of this company's margins on the same work and cannot buy Indian wages. It is a 4 and not a 5 because the protection is one-sided: it blocks American and European competitors but not Chinese ones or new Indian entrants, the buyers in this market deliberately keep a second supplier, and the prospectus never explains the growth in a single sentence.

This is the loudest number in the filing and it took real work to identify: domestic assembly for electronics makers, two-thirds to five-sixths of the line, supplying two of the company's five largest customers. Tooling, traded goods and powder sales were each ruled out from the filing's own numbers. The market behind it is named and funded — India-made mechanical parts and enclosures for electronics, headed for about USD 52 bn by 2030 from almost nothing, under a Rs 22,919 cr government programme notified in April 2025 and running to 2032. The company grew roughly fifteen times faster than that market. It holds well under 1% of it.

It is plainly winning and nobody can say why. Every advantage the moulding business would lend it is contradicted by the filing's own numbers: parts moulded fell 12%, capacity use fell, bought-in materials rose sharply, and tooling income fell 17% in the year this line tripled. The company states its customers have no binding agreements and can leave without cause or compensation; these two relationships are one and three years old against seventeen for its oldest moulding customers. The entry ticket, on its own lender's schedules, is a leased shed and about Rs 17 lakh. Aequs, Tata Electronics and Foxconn already do this work, and the customers are building their own enclosure capacity. The business also runs on a leased shed whose sub-lease expires around October 2028, with its pollution-control consent still pending when the prospectus was filed.

Medical is the fastest-growing use of this technology, about 12% a year, and once a part is qualified it is single-sourced because the volumes never justify a second supplier. Indo-MIM holds between 7% and 12% of it, with a market 14 times this segment's revenue by 2030. Two deductions keep it off a higher mark: the geographies it actually sells into — North America and Europe — grow nearer 9.5% and now carry a US tariff, and the growth rate is slowing from its recent past.

The single-sourcing lock is genuine but it is a feature of the industry, which protects every competitor equally — a right to keep work, not a right to win it. The proof is the customer count, frozen at 95 for two years: nothing new is being won. Last year's 31% jump is substantially an acquisition completed seven weeks into the year, four-fifths of whose price was goodwill; strip it out and the two-year rate is about 11%, at or below the market. And the mould belongs to the customer — the filing recognises tooling revenue when control of the tool passes to the buyer — so the customer can take the tool elsewhere.